(6-147) Retatrutide for Type 2 Diabetes and Obesity: An Investigational Triple Agonist of Glucagon-Like Peptide-1 (GLP-1), Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon Receptors
Tuesday, December 5, 2023
10:45 AM – 11:45 AM
Location: Hall E, Lower Level
Co-Author(s): Chaney Freese, Kaylen Schier, Benjamin Duren, Jeremy Johnson
